Compound Detail
CHEMBL4303241
BAY-1161909 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
COc1cc(S(C)(=O)=O)ccc1Nc1nc2ccc(-c3ccc(NC(=O)[C@H](C)c4ccc(F)cc4)cc3)cn2n1
Basic Information
| ChEMBL ID | CHEMBL4303241 |
| Name | BAY-1161909 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | NRJKIOCCERLIDG-GOSISDBHSA-N |
12
Targets
19
Activities
2
Assay Types
17
PK Parameters
20
Publications
6
Known Names
1
Indications
1
Mechanisms
Molecular Properties
559.6
MW (Da)
5.43
ALogP
8
HBA
2
HBD
114.7
PSA (Ų)
0.26
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dual specificity protein kinase TTK inhibitor | INHIBITOR | Dual specificity protein kinase TTK | ✓ | ✓ |
Indications
Neoplasms
Activity Summary
Kd 11 meas. best 9.14
IC50 8 meas. best 9.47
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dual specificity protein kinase TTK CHEMBL3983 | IC50 | 9.47 | 8.4433 | 0.3 | 6 |
| Dual specificity protein kinase TTK CHEMBL3983 | Kd | 9.14 | 9.14 | 0.7 | 1 |
| HeLa CHEMBL399 | IC50 | 7.25 | 6.915 | 56.0 | 2 |
| Mitogen-activated protein kinase 10 CHEMBL2637 | Kd | 7.02 | 7.02 | 96.0 | 1 |
| Mitogen-activated protein kinase 9 CHEMBL4179 | Kd | 6.8 | 6.8 | 160.0 | 1 |
| Mitogen-activated protein kinase 8 CHEMBL2276 | Kd | 6.62 | 6.62 | 240.0 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma CHEMBL1770034 | Kd | 6.55 | 6.55 | 280.0 | 1 |
| Mast/stem cell growth factor receptor Kit CHEMBL1936 | Kd | 6.43 | 6.43 | 370.0 | 1 |
| Serine/threonine-protein kinase 38 CHEMBL1075155 | Kd | 4.4 | 4.4 | 40000.0 | 1 |
| Serine/threonine-protein kinase mTOR CHEMBL2842 | Kd | 4.4 | 4.4 | 40000.0 | 1 |
| Serine/threonine-protein kinase BRSK2 CHEMBL4574 | Kd | 4.4 | 4.4 | 40000.0 | 1 |
| Misshapen-like kinase 1 CHEMBL5518 | Kd | 4.4 | 4.4 | 40000.0 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 1 CHEMBL5749 | Kd | 4.4 | 4.4 | 40000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 23.33 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 3.167 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 11.5 | mL.min-1.kg-1 | Mus musculus |
| CL | 3.167 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 214.43 | nM | Mus musculus |
| Cmax | 196.56 | nM | Rattus norvegicus |
| F | 49.0 | % | Rattus norvegicus |
| F | 63.0 | % | Canis lupus familiaris |
| F | 59.0 | % | Mus musculus |
| F | 49.0 | % | Rattus norvegicus |
| MRT | 1.072 | hr | Homo sapiens |
| T1/2 | 6.3 | hr | Canis lupus familiaris |
| T1/2 | 14.0 | hr | Rattus norvegicus |
| T1/2 | 4.9 | hr | Mus musculus |
| T1/2 | 14.0 | hr | Rattus norvegicus |
| Tmax | 4.0 | hr | Mus musculus |
| Tmax | 4.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Unchecked | 29 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | ADMET | 13 |
| 32338514 | 10.1021/acs.jmedchem.9b02035 | ADMET | 13 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Mitogen-activated protein kinase 10 | 5 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Mitogen-activated protein kinase 9 | 5 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Mitogen-activated protein kinase 8 | 5 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | U2OS | 4 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Dual specificity protein kinase TTK | 4 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Dual specificity mitogen-activated protein kinase kinase 7 | 3 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | HCT-116 | 3 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Dual specificity mitogen-activated protein kinase kinase 6 | 3 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Dual specificity mitogen-activated protein kinase kinase 4 | 3 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Tyrosine-protein kinase HCK | 3 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Glycogen synthase kinase-3 beta | 3 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | NCI-H1299 | 3 |
| 32338514 | 10.1021/acs.jmedchem.9b02035 | Dual specificity protein kinase TTK | 3 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Serine/threonine-protein kinase 38 | 2 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Serine/threonine-protein kinase mTOR | 2 |
| 26832791 | 10.1158/1535-7163.mct-15-0500 | Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | 2 |
Data from ChEMBL 36 via Core Engine